Modern (MRNA) Sɔɔtɔ Fɔrɛkɛst
Nɔnyɔ nyɛ$198.35Nɔɔ 25 Gbo 2026 20:54 UTC
Nyuɛ+1.80%
AI forecast: MRNA
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
Moderna, Inc. is a biotechnology company based in Cambridge, Massachusetts, that focuses on the discovery and development of messenger RNA-based therapeutics. The company creates synthetic mRNA that can be administered to patients to enable them to produce their own therapeutic proteins.
